Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis - Mantsiou, C; Karagiannis, T; Kakotrichi, P (Diabetes Obes Metab, 2020)